debate: ibd patient on biologic or immunomodulator who develops a malignancy - must stop these meds
Published 10 years ago • 163 plays • Length 11:32Download video MP4
Download video MP3
Similar videos
-
19:03
debate: ibd patient on biologic or immunomodulator who develops a malignancy - may continue meds
-
21:04
risks of malignancies due to ibd and immunomodulators and/or biologic therapy
-
32:29
keynote speaker: understanding the monitoring and safety of ibd medications and biologics
-
21:14
when and how to use immunomodulators and biologics in ibd
-
12:12
debate: immunomodulators and anti-tnfs must be stopped when an infection occurs
-
17:18
debate: asymptomatic uc patient on an immunomodulator with mucosal inflammation - no biologics
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
18:22
other major side effects due to immunomodulators and/or biologics in our ibd patients
-
1:03:27
diagnosing and monitoring ibd
-
3:52
the immune response and ibd
-
2:37
living with inflammatory bowel disease (ibd)
-
29:01
case discussion ii: the biologically-experienced ibd patient
-
12:53
biologic therapy should never be stopped, or should it?
-
27:32
ibd surgery debate 2: crohn's colitis
-
16:09
challenges in the management of ibd in elderly patients
-
18:55
how should we manage and follow the low risk ibd patient with mild disease?
-
29:35
the ibd patient in pain
-
27:21
inflammatory bowel disease and pregnancy
-
10:22
debate: asymptomatic uc patient on an immunomodulator with mucosal inflammation - add biologics
-
21:18
how can we prevent and manage the common side effects of immunomodulators and biologics?
-
2:36
biologic or biosimilar in ibd. it doesn’t matter which.
-
17:03
mimics of ibd